Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Holding BEAM?
Track your performance easily

Beam Therapeutics (BEAM) Technical Analysis

1,237 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Beam Therapeutics’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Beam Therapeutics is a Sell.
Beam Therapeutics’s (BEAM) 20-Day exponential moving average is 25.17, while Beam Therapeutics’s (BEAM) share price is $26.12, making it a Buy.
Beam Therapeutics’s (BEAM) 50-Day exponential moving average is 25.51, while Beam Therapeutics’s (BEAM) share price is $26.12, making it a Buy.

Beam Therapeutics (BEAM) Pivot Points

Sep 19, 2024, 11:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.58
24.38
24.98
25.78
26.38
27.18
27.78
Fibonacci
24.38
24.91
25.25
25.78
26.31
26.65
27.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Sep 19, 2024, 11:42 PM
Period
Simple
Exponential
MA5
25.48Buy
25.34Buy
MA10
24.61Buy
25.11Buy
MA20
25.22Buy
25.17Buy
MA50
26.27Sell
25.51Buy
MA100
24.96Buy
25.83Sell
MA200
27.35Sell
26.41Sell
Beam Therapeutics’s (BEAM) 10-Day exponential moving average is 25.11, while Beam Therapeutics’s (BEAM) share price is $26.12, making it a Buy.
Beam Therapeutics’s (BEAM) 100-Day exponential moving average is 25.83, while Beam Therapeutics’s (BEAM) share price is $26.12, making it a Sell.
Beam Therapeutics’s (BEAM) stock price is $26.12 and Beam Therapeutics’s (BEAM) 50-day simple moving average is 26.27, creating a Sell signal.
Beam Therapeutics’s (BEAM) stock price is $26.12 and Beam Therapeutics’s (BEAM) 100-day simple moving average is 24.96, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $26.12 and Beam Therapeutics’s (BEAM) 200-day simple moving average is 27.35, creating a Sell signal.

Beam Therapeutics (BEAM) Technical Indicators

Sep 19, 2024, 11:42 PM
Name
Value
Implied Action
RSI (14)
51.31
Neutral
STOCH (9,6)
68.92
Neutral
STOCHRSI (14)
53.98
Neutral
MACD (12,26)
-0.17
Sell
ADX (14)
14.65
Buy
Williams %R
-47.31
Buy
CCI (14)
41.08
Neutral
ATR (14)
1.43
-
Ultimate Oscillator
51.26
Neutral
ROC
-2.07
Sell
Beam Therapeutics’s (BEAM) Relative Strength Index (RSI) is 51.31, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Trend Strength Indicator (ADX) is 14.65, creating a Buy signal.
Beam Therapeutics’s (BEAM) Commodity Channel Index (CCI) is 41.08, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Price Rate of Change (ROC) is -2.07, creating a Sell signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Buy.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 51.31, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is -0.17, which suggests BEAM is a Sell.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 25.48, which suggests BEAM is a Buy.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 25.22, which suggests BEAM is a Buy.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 26.27, which suggests BEAM is a Sell.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 27.35, which suggests BEAM is a Sell.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -47.31, which suggests BEAM is a Buy.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is 41.08, which suggests BEAM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis